| - GRCh37:
- Chr3:111342589
- GRCh38:
- Chr3:111623742
| CD96 | | C syndrome | Uncertain significance
(Apr 11, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr3:111342670
- GRCh38:
- Chr3:111623823
| CD96 | | C syndrome | Uncertain significance
(May 6, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:111304239
- GRCh38:
- Chr3:111585392
| CD96 | | C syndrome, not provided | Benign/Likely benign
(Sep 4, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:111319608
- GRCh38:
- Chr3:111600761
| CD96 | D312fs, D328fs | C syndrome | Uncertain significance
(Apr 28, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:111296396-111296414
- GRCh38:
- Chr3:111577549-111577567
| CD96 | | C syndrome | Uncertain significance | criteria provided, single submitter |
| - GRCh37:
- Chr3:111304212
- GRCh38:
- Chr3:111585365
| CD96 | D265G, D281G | C syndrome | Uncertain significance
(Jun 3, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr3:111368561
- GRCh38:
- Chr3:111649714
| CD96 | P540S, P556S | C syndrome | Uncertain significance
(Jun 3, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr3:111356928
- GRCh38:
- Chr3:111638081
| CD96 | N464D, N480D | C syndrome | Uncertain significance
(Apr 15, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr3:111298044-111298045
- GRCh38:
- Chr3:111579197-111579198
| CD96 | I256fs, I240fs | C syndrome | Uncertain significance
(Aug 2, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr3:111370747
- GRCh38:
- Chr3:111651900
| CD96 | | C syndrome | Uncertain significance
(Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr3:111370743-111370744
- GRCh38:
- Chr3:111651896-111651897
| CD96 | | C syndrome | Uncertain significance
(Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr3:111370743-111370744
- GRCh38:
- Chr3:111651896-111651897
| CD96 | | C syndrome | Uncertain significance
(Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr3:111370743-111370747
- GRCh38:
- Chr3:111651896-111651900
| CD96 | | C syndrome | Uncertain significance
(Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr3:111370731
- GRCh38:
- Chr3:111651884
| CD96 | | C syndrome | Benign
(Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr3:111370729
- GRCh38:
- Chr3:111651882
| CD96 | | C syndrome | Uncertain significance
(Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr3:111370017
- GRCh38:
- Chr3:111651170
| CD96 | | C syndrome | Uncertain significance
(Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr3:111369522
- GRCh38:
- Chr3:111650675
| CD96 | | C syndrome | Likely benign
(Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr3:111369497
- GRCh38:
- Chr3:111650650
| CD96 | | C syndrome | Uncertain significance
(Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr3:111368825
- GRCh38:
- Chr3:111649978
| CD96 | | C syndrome | Uncertain significance
(Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr3:111261145-111261146
- GRCh38:
- Chr3:111542298-111542299
| CD96 | V19fs | not provided, C syndrome | Conflicting interpretations of pathogenicity
(May 20, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr3:111304209
- GRCh38:
- Chr3:111585362
| CD96 | T280M, T264M | C syndrome | Pathogenic
(Oct 1, 2007) | no assertion criteria provided |
| | CD96 | | C syndrome | Pathogenic
(Oct 1, 2007) | no assertion criteria provided |